JUAN LIU: Open Payments
NPI 1396100095 · ELLICOTT CITY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,438 in 126 payments from 19 companies in 2025. Trend: 2023 $843 · 2024 $1,548 · 2025 $2,438
Food & beverage: $2,438
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $395 |
| Novartis Pharmaceuticals Corporation | 12 | $258 |
| Galderma Laboratories, L.P. | 22 | $251 |
| Incyte Corporation | 8 | $205 |
| Janssen Biotech, Inc. | 15 | $191 |
| GENZYME CORPORATION | 7 | $184 |
| LEO Pharma Inc. | 7 | $180 |
| Organon LLC | 12 | $176 |
| Arcutis Biotherapeutics, Inc. | 4 | $95 |
| Regeneron Healthcare Solutions, Inc. | 3 | $94 |
Products named: DUPIXENT, COSENTYX, RINVOQ, OPZELURA, TREMFYA, SKYRIZI, NEMLUVIO, ADBRY.
Industry payments across MD — which companies pay providers there.
